Disclosures for "A Placebo Controlled Trial of Baricitinib in People on ART to Reduce CNS HIV"
-
The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
-
Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
-
Dr. Harrison has nothing to disclose.
-
Dr. Nguyen has nothing to disclose.
-
Ryan Peterson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Flaherty Sensabaugh Bonasso.
-
Dr. Gopinath has nothing to disclose.
-
Author has nothing to disclose
-
Ms. Alvarez has nothing to disclose.
-
The institution of Prof. Easley has received research support from Emory University.
-
Dr. Marconi has nothing to disclose.
-
Dr. Gavegnano has nothing to disclose.
-
An immediate family member of Dr. Fleischer has stock in Greenlight. The institution of Dr. Fleischer has received research support from NIH. Dr. Fleischer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH. Dr. Fleischer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISMRM.